Hostname: page-component-76fb5796d-vfjqv Total loading time: 0 Render date: 2024-04-26T01:03:45.724Z Has data issue: false hasContentIssue false
  • English
  • Français

The immunohistochemical expression of p21WAF1/Cip1 and Proliferating cell nuclear antigen in laryngeal squamous cell carcinomas

Published online by Cambridge University Press:  25 September 2006

X Li ,
S Izumaru ,
K Sakamoto ,
Y Miyajima  and
T Nakashima
X Li
Affiliation:
Department of Otolaryngology-Head and Neck Surgery, Shanghai First People's Hospital, Shanghai, China
S Izumaru
Affiliation:
Department of Otolaryngology-Head and Neck Surgery, Kurume University School of Medicine, Kurume, Japan
K Sakamoto
Affiliation:
Department of Otolaryngology-Head and Neck Surgery, Kurume University School of Medicine, Kurume, Japan
Y Miyajima
Affiliation:
Department of Otolaryngology-Head and Neck Surgery, Kurume University School of Medicine, Kurume, Japan
T Nakashima
Affiliation:
Department of Otolaryngology-Head and Neck Surgery, Kurume University School of Medicine, Kurume, Japan
Get access Rights & Permissions [Opens in a new window]

Abstract

The purpose of this study was to assess the significance of the expression of p21WAF1/Cip1 and proliferating cell nuclear antigen (PCNA) in human laryngeal squamous cell carcinomas. Forty-eight patients (25 supraglottic, 23 glottic) who had undergone operations between 1998 and 2003 were included in this study. The Envision immunohistochemistry method was utilized to stain these tissue specimens. The results showed that the immunostaining of p21WAF1/Cip1 do not show any correlation with differentiation, N stage, metastasis, survival, recurrence or the laryngeal site of involvement. A significant inverse correlation was detected between p21WAF1/Cip1 and the T stage. In contrast, the percentage of PCNA labelled cells showed a significant correlation with the T stage, but not with other clinicopathological parameters. There were differences in the expression of p21WAF1/Cip1 and PCNA between the supraglottic and the glottic carcinomas. In conclusion, our findings suggest that p21WAF1/Cip1 and PCNA may play an important role in the progression of carcinoma of the supraglottic larynx.

Keywords

P21 Cyclin Kinase InhibitorProliferating Cell Nuclear AntigenHead and Neck NeoplasmsLarynx Neoplasms
Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 120 , Issue 12 , December 2006 , pp. 1042 - 1048
Copyright
2006 JLO (1984) Limited

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)